Botulinum Toxin Therapy in Hidradenitis Suppurativa — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Botulinum Toxin Therapy in Hidradenitis Suppurativa — Stella

Recruiting

Back to Hidradenitis Suppurativa trials

Trial locations(1 site)

United States

University of Massachusetts Chan Medical School, Worcester, Massachusetts

Key details

Sponsor

University of Massachusetts, Worcester

Collaborators

Hidradenitis Suppurativa Foundation, National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

Enrollment target

~20 participants

Started

June 2022

Primary completion

April 2028

Age range

18 Years – 75 Years

Last updated September 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov